BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37601677)

  • 1. Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer.
    Xu G; Zhao Z; Wysham WZ; Roque DR; Fang Z; Sun W; Yin Y; Deng B; Shen X; Zhou C; Bae-Jump V
    Front Oncol; 2023; 13():1219923. PubMed ID: 37601677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
    Pierce SR; Fang Z; Yin Y; West L; Asher M; Hao T; Zhang X; Tucker K; Staley A; Fan Y; Sun W; Moore DT; Xu C; Tsai YH; Parker J; Prabhu VV; Allen JE; Lee D; Zhou C; Bae-Jump V
    J Exp Clin Cancer Res; 2021 Feb; 40(1):61. PubMed ID: 33557912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines.
    Wysham WZ; Roque DR; Han J; Zhang L; Guo H; Gehrig PA; Zhou C; Bae-Jump VL
    Target Oncol; 2016 Dec; 11(6):763-769. PubMed ID: 27188391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
    Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
    Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer.
    Zhao Z; Wang J; Kong W; Fang Z; Coleman M; Milne G; Burkett WC; Newton MA; Lee D; Deng B; Shen X; Suo H; Sun W; Hursting S; Zhou C; Bae-Jump VL
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer.
    Zhao Z; Wang J; Kong W; Fang Z; Coleman MF; Milne GL; Burkett WC; Newton MA; Lara O; Lee D; Deng B; Shen X; Suo H; Sun W; Hursting SD; Zhou C; Bae-Jump VL
    Gynecol Oncol; 2024 Apr; 186():126-136. PubMed ID: 38669767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: role of adipokines.
    Malvi P; Chaube B; Pandey V; Vijayakumar MV; Boreddy PR; Mohammad N; Singh SV; Bhat MK
    Mol Oncol; 2015 Mar; 9(3):689-703. PubMed ID: 25499031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.
    Qiu J; Zhao Z; Suo H; Paraghamian SE; Hawkins GM; Sun W; Zhang X; Hao T; Deng B; Shen X; Zhou C; Bae-Jump V
    Cancer Biol Ther; 2024 Dec; 25(1):2325130. PubMed ID: 38465855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different effects of psyllium husk and orlistat on weight control, the amelioration of hypercholesterolemia and non-alcohol fatty liver disease in obese mice induced by a high-fat diet.
    Deng Z; Meng C; Huang H; Song S; Fu L; Fu Z
    Food Funct; 2022 Aug; 13(17):8829-8849. PubMed ID: 35920178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women.
    Tiikkainen M; Bergholm R; Rissanen A; Aro A; Salminen I; Tamminen M; Teramo K; Yki-Järvinen H
    Am J Clin Nutr; 2004 Jan; 79(1):22-30. PubMed ID: 14684393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelidium elegans Regulates the AMPK-PRDM16-UCP-1 Pathway and Has a Synergistic Effect with Orlistat on Obesity-Associated Features in Mice Fed a High-Fat Diet.
    Choi J; Kim KJ; Koh EJ; Lee BY
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28358328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orlistat attenuates obesity-induced decline in steroidogenesis and spermatogenesis by up-regulating steroidogenic genes.
    Suleiman JB; Nna VU; Othman ZA; Zakaria Z; Bakar ABA; Mohamed M
    Andrology; 2020 Sep; 8(5):1471-1485. PubMed ID: 32438512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats.
    Karimi G; Sabran MR; Jamaluddin R; Parvaneh K; Mohtarrudin N; Ahmad Z; Khazaai H; Khodavandi A
    Food Nutr Res; 2015; 59():29273. PubMed ID: 26699936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-induced testicular oxidative stress, inflammation and apoptosis: Protective and therapeutic effects of orlistat.
    Suleiman JB; Nna VU; Zakaria Z; Othman ZA; Bakar ABA; Mohamed M
    Reprod Toxicol; 2020 Aug; 95():113-122. PubMed ID: 32450208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders.
    Svendsen M; Tonstad S
    Nutr J; 2011 Mar; 10():21. PubMed ID: 21385420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
    Finer N; James WP; Kopelman PG; Lean ME; Williams G
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo.
    Dowling S; Cox J; Cenedella RJ
    Lipids; 2009 Jun; 44(6):489-98. PubMed ID: 19381703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.